UNITEDHEALTH GROUP INCORPORATED (Delaware)
UNHUnitedHealth Group Incorporated is a diversified healthcare company based in the United States. It operates primarily through two segments: UnitedHealthcare, which provides health insurance and benefits services, and Optum, which offers health services including pharmacy care, healthcare technology, and information-intensive services. Established in 1977 and headquartered in Minnetonka, Minnesota, UnitedHealth Group is one of the largest healthcare organizations globally, focusing on improving health care access, affordability, and quality.
Dividend History
Investors can expect a dividend payout of $2.21 per share, scheduled to be distributed in 8 days on December 16, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 16, 2025 | $2.21 | 2025-12-08 | 2025-12-08 |
| September 23, 2025 | $2.21 | 2025-09-15 | 2025-09-15 |
| June 24, 2025 | $2.21 | 2025-06-16 | 2025-06-16 |
| March 18, 2025 | $2.10 | 2025-03-10 | 2025-03-10 |
| December 17, 2024 | $2.10 | 2024-12-09 | 2024-12-09 |
Dividends Summary
- UNITEDHEALTH GROUP INCORPORATED (Delaware) has issued 70 dividend payments over the past 21 years
- The most recent dividend was paid 76 days ago, on September 23, 2025
- The highest dividend payed out to investors during this period was $2.21 per share
- The average dividend paid during this period was $0.86 per share.
Company News
Warren Buffett has been selling stocks and accumulating cash, signaling potential concerns about current market valuations. He suggests investors diversify portfolios, look for buying opportunities, and maintain cash reserves for strategic investments before 2026.
UnitedHealth Group has agreed to sell its remaining South American operation, Banmedica, to Brazilian private equity firm Patria Investments for $1 billion, continuing its strategy to streamline operations and exit Latin American markets.
The global healthcare quality management market is projected to grow from $1.42 billion in 2025 to $2.51 billion by 2030, with a 12.1% CAGR, driven by increased focus on patient safety, clinical quality, and regulatory compliance.
Fiserv reported disappointing Q3 earnings, with revenue and earnings missing analyst expectations, leading to a 30% stock collapse and a comprehensive strategic restructuring including leadership changes and reduced financial guidance.
Elevance Health reported strong Q2 2024 earnings, with adjusted EPS of $10.12 beating estimates. However, the company saw a decline in medical membership and premium revenues, impacting overall margins. The results were driven by improved product revenues in the CarelonRx business and higher net investment income.
